# Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

> **NCT06049654** · NA · RECRUITING · sponsor: **Fundación EPIC** · enrollment: 104 (estimated)

## Conditions studied

- Aortic Valve Stenosis
- Structural Valve Deterioration

## Interventions

- **DEVICE:** NVT ALLEGRA TAVI System TF
- **DEVICE:** EDWARDS SAPIEN 3 or SAPIEN ULTRA SYSTEM

## Key facts

- **NCT ID:** NCT06049654
- **Lead sponsor:** Fundación EPIC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2026-11-01
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2025-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06049654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06049654, "Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06049654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*